What is the recommended dose of Bactrim (sulfamethoxazole/trimethoprim) for treating a wound infection indicated by a wound swab?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim Dosing for Wound Infections

For wound infections in adults, prescribe Bactrim 1-2 double-strength tablets (160mg/800mg trimethoprim/sulfamethoxazole) orally twice daily for 7-10 days. 1, 2

Adult Dosing Regimen

  • Standard oral dose: 1-2 double-strength tablets (160mg/800mg TMP/SMX) twice daily for 7-10 days 1, 2
  • For MRSA-confirmed infections: Extend treatment to 10 days to reduce recurrence risk 1
  • Severe/complicated infections requiring IV therapy: 8-12 mg/kg/day (based on trimethoprim component) divided into 4 doses 3, 1

Pediatric Dosing

  • Children >2 months: 8-12 mg/kg/day (based on trimethoprim component) divided into 2 doses orally or 4 doses IV 3, 1, 2
  • Contraindicated in infants <2 months of age 1

Clinical Context for Appropriate Use

When Bactrim is Appropriate:

  • Purulent wound infections or abscesses where MRSA is suspected or confirmed 1
  • Surgical site infections involving trunk or extremity away from axilla/perineum 3
  • After beta-lactam failure as empiric coverage 1
  • Bactrim achieves excellent skin penetration with blister fluid concentrations reaching 82-94% of plasma levels 4

Critical Limitation - Streptococcal Coverage:

  • Bactrim lacks reliable streptococcal coverage and should be combined with a beta-lactam (e.g., amoxicillin or cephalexin) for non-purulent cellulitis 1
  • For surgical wounds near axilla or perineum, add metronidazole for anaerobic coverage 3
  • For animal/human bites, combine with metronidazole or use amoxicillin-clavulanate instead due to poor anaerobic activity 1

Evidence Supporting Efficacy

  • A 2016 randomized trial demonstrated 92% cure rates for uncomplicated wound infections with TMP-SMX, equivalent to clindamycin, though clindamycin showed lower recurrence rates (2.0% vs 7.1%) 5
  • For drained abscesses, TMP-SMX achieved 92.9% cure rates versus 85.7% with placebo, with significantly fewer subsequent infections at new sites (3.1% vs 10.3%) 6

Safety Considerations and Contraindications

  • Avoid in third trimester pregnancy (FDA Category C/D) 1
  • Monitor carefully with methotrexate due to severe drug interactions 1
  • Sulfa allergy: Use alternatives (clindamycin 300mg TID, doxycycline 100mg BID, or linezolid) 1
  • Mild gastrointestinal side effects are common but generally well-tolerated 6

Alternative Agents When Bactrim is Inappropriate

  • Clindamycin: 300-450mg four times daily orally or 600mg every 8 hours IV (if local MRSA resistance <10%) 3, 1
  • Doxycycline: 100mg twice daily (adults only, not for children <8 years) 3, 1
  • Cephalexin: 500mg four times daily for MSSA-only infections 3, 2

References

Guideline

Bactrim Dosing and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bactrim Dosing for Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.